Ipamorelin

Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist, recognized in research for its ability to stimulate growth hormone release with high specificity and minimal off-target effects.

Key Research Areas

• Growth Hormone Stimulation: Ipamorelin selectively stimulates the pituitary gland to release growth hormone without significantly affecting cortisol, prolactin, or ACTH levels — a key differentiator from other GH secretagogues.
• Body Composition: Preclinical studies suggest potential effects on lean muscle mass preservation and fat metabolism through GH-mediated pathways.
• Bone Density: Research indicates possible positive effects on bone mineral density via IGF-1 upregulation.
• Recovery & Sleep: GH pulses stimulated by Ipamorelin align with natural circadian rhythms, making it a subject of interest in recovery and sleep quality research.
• Anti-aging Research: As GH levels decline with age, Ipamorelin is studied as a tool to investigate GH restoration and its downstream effects on cellular aging markers.

Mechanism of Action

Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) that acts as a selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R1a). Unlike GHRP-6 or GHRP-2, it does not significantly stimulate appetite or cortisol release, making it one of the cleanest GH secretagogues studied to date.

Formulation

BE·1 Labs Ipamorelin is supplied as a lyophilized (freeze-dried) powder in a sealed research vial, ensuring maximum stability and purity. Each vial contains 5mg of Ipamorelin.

Research Use Only

This product is intended exclusively for in-vitro research and laboratory use. It is not approved for human consumption, therapeutic use, or veterinary application.